Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Dolmetsch

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Neurology. Clinical Practice|April 3, 2025
Suicidal Ideation and Sleep Disturbances Among People With Huntington Disease: Evidence From the HDBOI StudyIdaira Rodríguez Santana, Samuel A Frank, Tiago A Mestre, et al.
Plos One|March 19, 2013
Cytoplasmic location of α1A voltage-gated calcium channel C-terminal fragment (Cav2.1-CTF) aggregate is sufficient to cause cell deathMakoto Takahashi, Masato Obayashi, Taro Ishiguro, et al.
Blood Advances|December 9, 2022
Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapyAnnette von Drygalski, Esteban Gomez, Adam Giermasz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2022
Evaluating the state of the science for adeno-associated virus integration: An integrated perspectiveDenise E Sabatino, Frederic D Bushman, Randy J Chandler, et al.
Acta Neuropathologica|January 1, 2010
The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cellsTaro Ishiguro, Kinya Ishikawa, Makoto Takahashi, et al.
Science Translational Medicine|April 2, 2025
Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trialBaltazar Gomez-Mancilla, Kenneth M Dürsteler, Marc Vogel, et al.
Nature Medicine|June 13, 2018
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cellsRobert J Ihry, Kathleen A Worringer, Max R Salick, et al.
Nature Neuroscience|October 28, 2016
Translating genome-wide association findings into new therapeutics for psychiatryGerome Breen, Qingqin Li, Bryan L Roth, et al.
Nature Communications|March 4, 2022
An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusionCaroline Gubser Keller, Youngah Shin, Alex Mas Monteys, et al.
Communications Biology|June 15, 2021
Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neuronsCarlos G Sanchez, Christopher M Acker, Audrey Gray, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neurology. Clinical Practice|April 3, 2025
Suicidal Ideation and Sleep Disturbances Among People With Huntington Disease: Evidence From the HDBOI StudyIdaira Rodríguez Santana, Samuel A Frank, Tiago A Mestre, et al.
Plos One|March 19, 2013
Cytoplasmic location of α1A voltage-gated calcium channel C-terminal fragment (Cav2.1-CTF) aggregate is sufficient to cause cell deathMakoto Takahashi, Masato Obayashi, Taro Ishiguro, et al.
Blood Advances|December 9, 2022
Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapyAnnette von Drygalski, Esteban Gomez, Adam Giermasz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2022
Evaluating the state of the science for adeno-associated virus integration: An integrated perspectiveDenise E Sabatino, Frederic D Bushman, Randy J Chandler, et al.
Acta Neuropathologica|January 1, 2010
The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cellsTaro Ishiguro, Kinya Ishikawa, Makoto Takahashi, et al.
Science Translational Medicine|April 2, 2025
Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trialBaltazar Gomez-Mancilla, Kenneth M Dürsteler, Marc Vogel, et al.
Nature Medicine|June 13, 2018
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cellsRobert J Ihry, Kathleen A Worringer, Max R Salick, et al.
Nature Neuroscience|October 28, 2016
Translating genome-wide association findings into new therapeutics for psychiatryGerome Breen, Qingqin Li, Bryan L Roth, et al.
Nature Communications|March 4, 2022
An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusionCaroline Gubser Keller, Youngah Shin, Alex Mas Monteys, et al.
Communications Biology|June 15, 2021
Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neuronsCarlos G Sanchez, Christopher M Acker, Audrey Gray, et al.
Pageof 3